Lifespot Health gains on placement to fund clinical trial of inhaler devices

Nexalis Therapeutics

04/11/2020 04:15

** Shares of Lifespot Health Ltd  LSH.AX  rise as much as
3.4% to A$0.061 - biggest intraday pct gain since Oct. 20
    ** Medical technology firm enters agreement to place 13.1
mln shares at issue price of A$0.055 per share to M I D Wealth
Pty Ltd, raising A$720,500 ($512,131.40)  urn:newsml:reuters.com:*:nASXbyddGm
    ** Proceeds to be used to fund clinical trials on co's
Medihale inhaler device and other novel cannabinoid inhalational
devices, among others - LSH
    ** New shares represent 20% of co's free float and are
priced at a discount of 6.8%
    ** Stock has risen 73.5% this year, as of last close

($1 = 1.4069 Australian dollars)

 (Reporting by Yamini C S in Bengaluru)
 ((Yamini.CS@thomsonreuters.com;))